Most research on dementia risk gives us percentages. Your risk goes up by this much; your odds go up by that much. Useful for researchers, but hard to feel.
A new analysis from the Atherosclerosis Risk in Communities study, published in Neurology Open Access, does something different. It converts vascular risk into years. Specifically, it asks how many years a person can expect to live both alive and free of dementia, starting at age 55, depending on how many vascular risk factors they carried in midlife.
The answer is stark. People entering their late fifties with none of the three risk factors averaged 30.1 dementia-free years. People with all three averaged 17.5. That is a gap of roughly 12.6 years of intact cognitive life.
What was measured
The ARIC study enrolled adults from four US communities beginning in the late 1980s. This analysis used the 1990-1992 examination as its starting point and followed 12,409 participants, with an average age of 56.2 years and 56% women, for a median of 26.3 years. Over that time, 3,008 developed dementia and 5,238 died without ever developing it.
Three midlife risk factors were counted, each defined objectively where possible: diabetes (a physician diagnosis, diabetes medication, or a hemoglobin A1c of 6.5% or higher), hypertension (blood pressure of 140/90 mm Hg or higher, or use of blood pressure medication), and current smoking. Each participant received a simple score from 0-3.
Dementia was not identified casually. It came from repeated in-person cognitive testing batteries, telephone interviews with participants and family informants, continuous surveillance of hospital and death records, and expert panel adjudication of every case. Deaths were captured through the National Death Index and multiple other sources.
The core finding
Dementia-free years from age 55, by number of midlife risk factors:
Zero risk factors averaged 30.1 years. One risk factor averaged 26.3 years. Two averaged 21.0 years. Three averaged 17.5 years.
The pattern is a clean dose-response. Each additional risk factor cost roughly 4-5 years of cognitively intact life.
The hazard ratios tell the same story from a different angle. Compared with those carrying no risk factors, people with all three had 2.69 times the hazard of developing dementia and 5.61 times the hazard of dying before dementia ever had the chance to develop.
That second number deserves a pause. The vascular burden did not primarily threaten these participants with dementia. It threatened them with death. The dementia incidence rate rose modestly, from 8.8 to 12.5 cases per 1,000 person-years across the risk groups. The death rate rose fourfold, from 10.5 to 42.3 per 1,000 person-years.
The finding that will be misread
Here is where careful reading matters, because this result is genuinely counterintuitive and could easily be twisted.
By age 95, the group with zero midlife risk factors had the highest cumulative incidence of dementia at 42%, while the group with three risk factors had only 23%.
That is not a case for hypertension and smoking. It is arithmetic. To develop dementia, you have to live long enough to develop it. By age 75, more than half of the three-risk-factor group, 53%, had already died without dementia, compared with 10% of the group with no risk factors. By age 85, only 7% of the highest-risk group was still alive and dementia-free, compared with 35% of the lowest-risk group.
The high-risk group did not avoid dementia. They were removed from the running by earlier death from other causes. In fact, dementia arrived earlier in that group when it arrived at all: by age 75, cumulative dementia incidence was 10% with three risk factors versus 3% with none.
This is what statisticians call competing risk, and it’s why simple incidence percentages can mislead so badly in older populations. The time-based measure used here handles it honestly. Good vascular health buys years of life, and some of those additional years carry dementia risk simply because they are late-life years. It does not, however, trade cognition for longevity. The zero-risk-factor group lived 12.6 more years with an intact mind.
One more detail followed the same theme. Among participants who did develop dementia, average survival afterward ranged from 4.1 years in the zero-risk group down to 3.0 years in the three-risk group. So the higher-burden group spent a larger fraction of whatever remaining life they had living with dementia rather than without it.
Who this held true for
The researchers checked whether the pattern differed across groups, and the inverse relationship between vascular burden and dementia-free years held in every subgroup examined.
Women averaged more dementia-free years than men, 28.1 versus 25.6 overall. Black participants averaged fewer than White participants, 24.6 versus 27.8, and that gap widened at higher levels of vascular burden, reaching 16.0 versus 19.6 years among those with all three risk factors. The authors note that Black participants in this cohort also carried a higher burden of vascular risk factors to begin with, which suggests prevention efforts may yield their largest returns in exactly the populations where the burden is heaviest.
Genetics mattered, but did not override the pattern. Carriers of the APOE-e4 allele averaged 25.6 dementia-free years compared with 27.6 for noncarriers. Carrying two copies raised the hazard of dementia more than threefold. Yet within both carriers and noncarriers, going from zero to three vascular risk factors cost more than 11 years. Genes load the gun, but vascular health still has a hand on the trigger.
Other measured factors moved in expected directions. Higher education, more physical activity, and absence of prior stroke were each associated with a lower hazard of the combined outcome, while extreme obesity raised it.
What this study cannot tell you
This is observational research. It shows association, not proof of causation, and residual confounding cannot be ruled out.
The researchers measured vascular risk factors once, in midlife, and carried them forward. That has an advantage, since it avoids the trap of early cognitive decline influencing later blood pressure treatment. But it cannot capture what happened afterward. Someone who quit smoking at 58 or brought their A1c down at 60 is counted here by their status in 1991. Because risk factors generally worsen over time, the authors suggest this approach likely understates the true cumulative impact.
Only 176 participants carried all three risk factors, which is why the estimates for that group have wider margins than the others. And the count itself was deliberately simple: three factors weighted equally, rather than a comprehensive cardiometabolic assessment.
The practical takeaway
The three factors in this study are among the most modifiable in all of medicine.
Blood pressure responds to weight, sodium, potassium, exercise, sleep, alcohol reduction, and medication when needed. Blood sugar responds to diet composition, activity, muscle mass, and weight. Smoking responds to cessation, and the benefit begins quickly. None of these requires a breakthrough therapy. They require attention, measurement, and follow-through during the decade when most people feel fine and assume nothing needs addressing.
That is the window this study is really about: roughly ages 45-65, when hypertension is silent, when a rising A1c looks like a lab value rather than a warning, and when the temptation is to defer. The consequences of those years did not become visible in this cohort until the 2010s and 2020s.
The most useful reframe here is the one the authors chose. The question is not only how long you will live, or whether you will get a particular diagnosis. It is how many years you can expect to be present, oriented, and yourself with the people you love. That number is not fixed at birth. In this study, it varied by more than a decade based on three things measurable at a routine visit.
The body we have been given is remarkably responsive to care, and midlife is when that care compounds. If you are in your forties, fifties, or early sixties, the most valuable thing you can do this year is find out where your blood pressure, your hemoglobin A1c, and your vascular health actually stand, and then act on what you find. This article is educational and does not replace individualized medical advice.
